Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined position fell below the 3% threshold, holding 3,158 voting rights and 1,959,276 financial instruments. This fluctuation in ownership is reported in compliance with Belgian transparency laws. Ontex is a leading international producer of hygiene products, listed on Euronext Brussels, with operations mainly in Europe and North America.
The transparency declaration involving Goldman Sachs Group, Inc. is noted here alongside Pluang's Consumer Staples sector data. For readers following Consumer Staples, here is Pluang's market snapshot as of Nov 05, 2026 00:11 WIB: out of 63 priced US stocks, 57 rose and 4 fell. Notable movers include HLF (Herbalife Nutrition Ltd) at USD 15.34 with a 1-day change of +6.68%, CAG (Conagra Brands Inc) at USD 15.37 up +6.66%, and MKC (McCormick & Company, Incorporated) at USD 51.05 up +6.62%.
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...
